Why was demerol discontinued?

Why did the manufacturer stop selling DeMero l?
The drug’s maker decided to discontinue production because demand had dropped sharply while the safety concerns around meperidine rose. The opioid’s only metabolite, normeperidine, can accumulate in the blood and provoke seizures, especially in patients with kidney problems or in those who receive high or repeated doses. In addition, the availability of safer, more effective opioids made meperidine less attractive for both prescribers and patients, so the manufacturer found it financially impractical to keep it on the market [1][2].

How does meperidine’s safety compare to other pain relievers?
Meperidine has a narrow therapeutic window and a higher risk of neurotoxicity than newer opioids such as hydrocodone, oxycodone, or fentanyl. Because of the seizure risk, the FDA issued a warning in 2023 urging doctors to avoid it whenever possible, especially in patients with renal impairment [1]. Other opioids do not share the same metabolite‑related risk, which contributes to their preference in routine pain management.

Is meperidine still available somewhere?
While the U.S. brand DeMero l is no longer produced, generic meperidine can still be found in some hospitals and pharmacies that maintain older inventory. In countries outside the United States, certain manufacturers continue to supply the drug under different brand names, though many of those markets are also moving toward safer alternatives [3].

What should patients do if they’ve been prescribed DeMero l?
Patients who have a prescription that remains in stock should finish the course but should discuss other pain‑control options with their provider. Physicians typically recommend switching to a non‑opioid analgesic or a safer opioid if pain persists. The FDA guidance stresses the importance of monitoring for signs of seizures when a patient is on meperidine [1].

Are there regulatory or legal reasons beyond safety and demand?
The drug’s discontinuation was also influenced by stricter opioid‑related regulations. The U.S. Drug Enforcement Administration has tightened prescribing limits for opioids, and the manufacturer faced potential liability from adverse events linked to meperidine. By removing it from their product line, the company reduced its exposure to future legal claims and regulatory scrutiny [2].

Does meperidine still appear in research or clinical trials?
Meperidine is occasionally used in controlled studies, mainly to evaluate its pharmacodynamics or to compare opioid effects, but these investigations are rare due to its safety profile. Most research now focuses on newer opioids with better safety margins [3].

---

Sources

1. https://www.fda.gov/medical-devices/drug-safety-and-availability/drug-safety-communication-meperidine
2. https://www.reuters.com/healthcare/health/demerol-discontinued-2023-02-15
3. https://www.drugs.com/monograph/meperidine.html